Drug Approval Process – In United States of America, European Union and India: A Review

Publisher： Bentham Science Publishers

ISSN： 2213-476X

Source： Applied Clinical Research, Clinical Trials and Regulatory Affairs, Vol.1, Iss.1, 2014-04, pp. : 13-22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Predictors of orphan drug approval in the European Union

By Heemstra Harald  

European Journal of Clinical Pharmacology, Vol. 64, Iss. 5, 2008-05 ,pp. : 545-552

Springer Publishing Company

Access to resources Recommend Favorite

The US Government Accountability Office is to review a drug approval process used by the FDA

By  

Inpharma, Vol. 1, Iss. 1633, 2008-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Biopharmaceuticals approved in the EU 1995-1999: a European Union-United States comparison

By Reichert J.M.   Healy E.M.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 51, Iss. 1, 2001-01 ,pp. : 1-7

Elsevier

Access to resources Recommend Favorite

Learning from history: a review of David Bewley-Taylor's The United States and International Drug Control, 1909-1997

By Webster P.  

The International Journal of Drug Policy, Vol. 14, Iss. 4, 2003-08 ,pp. : 343-346

Elsevier

Access to resources Recommend Favorite

Oncology Drug Review Process

By Farrell Ann T.   Pazdur Richard  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 1, Iss. 1, 2003-03 ,pp. : 109-113

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite